InspireMD to Report First Quarter 2019 Financial Results and Provide Business Update on Tuesday, May 14
Management to host conference call and webcast at 8am ET
TEL AVIV, Israel, May 07, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, announced today that it will host a conference call and webcast on Tuesday, May 14, 2019, to discuss financial results for the first quarter ended March 31, 2019, and provide a corporate update.
|Conference Call & Webcast:|
|Tuesday, May 14th @ 8am Eastern Time|
|Within the US:||877-451-6152|
|Outside the US:||201-389-0879|
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet® technology to make its products the industry standard for treatment of carotid artery disease by providing outstanding acute results and durable stroke free long-term outcomes.
InspireMD’s common stock is quoted on the NYSE American under the ticker symbol NSPR and certain warrants are quoted on the NYSE American under the ticker symbol NSPR.WS.
Chief Financial Officer
LifeSci Advisors, LLC
Upcoming Life Sciences Events
- May 2019
- New York: Inhalation & Respiratory Drug Delivery 2019
- June 2019
- Philadelphia, PA: Product and Company Valuation Course
- Philadelphia: RESI Philadelphia